Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000019

Principal Accounting Officer gave up 1,163 shares (to pay taxes)

  • Principal Accounting Officer acquired 3,590 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Alenson Carman · Principal Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-16 Exercise or conversion : show line 1 in the form +790 974 D
2020-02-16 Exercise or conversion : show line 2 in the form +2,800 3,774 D
2020-02-18 Shares withheld for taxes : show line 3 in the form −1,163 $52.01 $60,488 2,611 D

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2020-02-14 Grant or award : show line 4 in the form Restricted stock units +2,666 2,666 D
2020-02-14 Grant or award : show line 5 in the form Restricted stock unit +4,800 4,800 D
2020-02-14 Grant or award : show line 6 in the form Stock option (right to buy) +5,332 5,332 D
2020-02-16 Exercise or conversion : show line 7 in the form Restricted stock units −790 790 D
2020-02-16 Exercise or conversion : show line 8 in the form Restricted stock units −2,800 0 D
Loading xslF345X03/wf-form4_158214930367652.xml…